Nintenib 150 Soft Gelatin Capsule
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Nintedanib (150mg)
Overview Nintenib 150 Soft Gelatin Capsule
Nintedanib 150 mg soft gelatin capsules are indicated for idiopathic pulmonary fibrosis and non-small cell lung carcinoma. This medication functions by inhibiting specific cellular pathways crucial to the development and advancement of these conditions, thereby hindering or retarding cancer cell proliferation. Administer Nintedanib 150 mg soft gelatin capsules with food, consistently at the same time daily for optimal therapeutic effect. Dosage and frequency are determined by your physician, based on your specific diagnosis and may be adjusted. Strict adherence to your prescribed regimen is crucial, as deviations or overdosage can lead to severe adverse reactions. While therapeutic benefits may not be immediately apparent, requiring weeks or months, discontinue use only under your physician's guidance. Diarrhea is a frequent side effect; ensure adequate hydration and report persistent symptoms to your doctor. Additional common side effects encompass nausea, abdominal discomfort, emesis, abnormal liver function test results, anorexia, cephalalgia, weight reduction, and hypertension. Liver function monitoring via blood tests may be requested by your physician. Prior to commencing therapy, disclose any bleeding disorders, hepatic or renal impairment, or concurrent use of anti-infective medications. Interactions with numerous other drugs are possible; comprehensive disclosure of all medications to your healthcare provider is essential. This medication is contraindicated during gestation and lactation. Employing effective contraception by both partners throughout treatment is imperative to prevent pregnancy.
Uses of Nintenib 150 Soft Gelatin Capsule
Managing idiopathic pulmonary fibrosis and non-small cell lung cancer.
Major Benefits of Nintenib 150 Soft Gelatin Capsule:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. The Nintenib 150mg softgel should be administered with a meal.
Common Side effects of Nintenib 150 Soft Gelatin Capsule:
- Diarrhea
- Nausea
- Abdominal pain
- Vomiting
- Abnormal liver function tests
- Loss of appetite
- Headache
- Weight loss
- High blood pressure
How to use Nintenib 150 Soft Gelatin Capsule:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the capsule whole; avoid chewing, crushing, or breaking it. The Nintenib 150 mg soft gelatin capsule should be administered with a meal.
How Nintenib 150 Soft Gelatin Capsule works:
Amcenib 150mg softgel capsules are an anticancer drug. Their mechanism of action involves inhibiting aberrant proteins responsible for cancerous cell proliferation. Additionally, they impede biological pathways leading to fibrosis, the excessive tissue scarring, thereby hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Nintenib 150 Soft Gelatin Capsules is undefined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Nintenib 150 mg soft gelatin capsules is contraindicated during pregnancy due to established risks to the fetus. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
The use of Nintenib 150 mg soft gelatin capsules while breastfeeding is likely unsafe. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a Nintenib 150mg softgel capsule may induce adverse reactions that impair driving ability. Nausea following administration might compromise safe driving.
KidneyCAUTION
Patients with severe kidney impairment should use Nintenib 150 mg soft gelatin capsules cautiously, as dose modification may be necessary. Limited data exists regarding the use of this medication in such individuals; therefore, physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Nintenib 150 mg soft gelatin capsules; dosage modification may be necessary. Consult your physician. Nintenib 150 mg soft gelatin capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Nintenib 150 Soft Gelatin Capsule :
Omit any missed Nintenib 150 mg softgel dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Nintenib 150 Soft Gelatin Capsule
| Label | Value |
|---|---|
| Chemical Type | Indole-carboxylic Acids |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | TKIs (Tyrosine Kinase Inhibitors) |
3,018 People bought this recently